However, mechanisms promoting selective killing of cancer cells remained unclear and were generally presumed to be dependent on loss of rapidly turned-over proteins, such as Myc or Mcl-1.66 Our study highlights that many of these drugs owe their lethality to activation of PDAR. This evidence concerns the gene MCL1 and cancer.